Document Detail


Productivity and Quality of Recombinant Proteins Produced by Stable CHO Cell Clones can be Predicted by Transient Expression in HEK Cells.
MedLine Citation:
PMID:  22915356     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Selection of lead candidates in drug discovery is a complex and time-consuming process. Here, we describe an approach that allows prediction of the productivity and quality of recombinant proteins by stable producer cell clones with the help of transient transfection studies. This is exemplified for three distinct bispecific T cell engager (BiTE(®))-a new class of single-chain antibody-based therapeutics showing very promising results in the treatment of cancer. BiTE(®) titers of transiently transfected HEK cells showed a striking correlation with titers of selected stable CHO cell clones. Likewise, the percentage of the monomeric BiTE(®) fraction in cell culture supernatants correlated well between transiently expressing HEK and stably expressing CHO cell clones. This validates the use of transient transfection studies for the selection of biopharmaceutical lead candidates with desired pharmaceutical properties.
Authors:
Carolin Diepenbruck; Matthias Klinger; Thomas Urbig; Patrick Baeuerle; Rüdiger Neef
Related Documents :
7082306 - Defective catabolism of low-density lipoprotein by fibroblasts from patients with i-cel...
1252356 - Incorporation of i-14c-acetate into the lipids of isolated epidermal cells.
15187166 - Alterations in lipid raft composition and dynamics contribute to abnormal t cell respon...
22689306 - Giant vesicles "colonies": a model for primitive cell communities.
22582276 - Flavobacterium johnsoniae rema is a mobile cell surface lectin involved in gliding.
19200636 - Stem cell characteristics in prostate cancer cell lines.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-8-23
Journal Detail:
Title:  Molecular biotechnology     Volume:  -     ISSN:  1559-0305     ISO Abbreviation:  Mol. Biotechnol.     Publication Date:  2012 Aug 
Date Detail:
Created Date:  2012-8-23     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9423533     Medline TA:  Mol Biotechnol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Amgen Research (Munich) GmbH, Staffelseestr. 2, 81477, Munich, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Appropriateness of the treatment of fatigued patients with stage IV cancer.
Next Document:  Shapes and Internal Dynamics of the 1:1 Adducts of Ammonia with trans and gauche?Ethanol: A Rotation...